Mataramvura H, Bunders M, Duri K
Front Immunol. 2023; 14:1182217.
PMID: 37350953
PMC: 10282157.
DOI: 10.3389/fimmu.2023.1182217.
Mwesigwa S, Williams L, Retshabile G, Katagirya E, Mboowa G, Mlotshwa B
NPJ Genom Med. 2021; 6(1):24.
PMID: 33741997
PMC: 7979878.
DOI: 10.1038/s41525-021-00185-w.
Nagaraja P, Gopalan B, DSouza R, Sarkar D, Rajnala N, Dixit N
Sci Rep. 2021; 11(1):2990.
PMID: 33542308
PMC: 7862260.
DOI: 10.1038/s41598-021-82293-2.
Arrym M, Martins Alves P, Castelhano M, Mazzola T, Muller Banzato Pinto de Lemos R, Zaccariotto T
Braz J Infect Dis. 2019; 23(3):151-159.
PMID: 31271732
PMC: 9428219.
DOI: 10.1016/j.bjid.2019.06.002.
Koor G, Paximadis M, Picton A, Karatas F, Loubser S, He W
Clin Immunol. 2019; 205:16-24.
PMID: 31100442
PMC: 6646080.
DOI: 10.1016/j.clim.2019.05.009.
Increased Regulatory T-Cell Activity and Enhanced T-Cell Homeostatic Signaling in Slow Progressing HIV-infected Children.
Roider J, Ngoepe A, Muenchhoff M, Adland E, Groll A, Ndungu T
Front Immunol. 2019; 10:213.
PMID: 30809229
PMC: 6379343.
DOI: 10.3389/fimmu.2019.00213.
HIV control: Is getting there the same as staying there?.
Goulder P, Deeks S
PLoS Pathog. 2018; 14(11):e1007222.
PMID: 30383857
PMC: 6211749.
DOI: 10.1371/journal.ppat.1007222.
HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes.
Ditse Z, Muenchhoff M, Adland E, Jooste P, Goulder P, Moore P
J Virol. 2018; 92(17).
PMID: 29950423
PMC: 6096808.
DOI: 10.1128/JVI.00878-18.
Immune activation despite preserved CD4 T cells in perinatally HIV-infected children and adolescents.
Alvarez P, Mwamzuka M, Marshed F, Kravietz A, Ilmet T, Ahmed A
PLoS One. 2017; 12(12):e0190332.
PMID: 29287090
PMC: 5747457.
DOI: 10.1371/journal.pone.0190332.
Role of HIV-specific CD8 T cells in pediatric HIV cure strategies after widespread early viral escape.
Leitman E, Thobakgale C, Adland E, Ansari M, Raghwani J, Prendergast A
J Exp Med. 2017; 214(11):3239-3261.
PMID: 28983013
PMC: 5679167.
DOI: 10.1084/jem.20162123.
Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
Prendergast A, Chasekwa B, Rukobo S, Govha M, Mutasa K, Ntozini R
J Infect Dis. 2017; 216(6):651-661.
PMID: 28934432
PMC: 5853317.
DOI: 10.1093/infdis/jix367.
Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection.
Muenchhoff M, Adland E, Karimanzira O, Crowther C, Pace M, Csala A
Sci Transl Med. 2016; 8(358):358ra125.
PMID: 27683550
PMC: 6087524.
DOI: 10.1126/scitranslmed.aag1048.
Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
Prendergast A, Szubert A, Berejena C, Pimundu G, Pala P, Shonhai A
J Infect Dis. 2016; 214(2):226-36.
PMID: 27190179
PMC: 4918830.
DOI: 10.1093/infdis/jiw148.
Immune activation and paediatric HIV-1 disease outcome.
Roider J, Muenchhoff M, Goulder P
Curr Opin HIV AIDS. 2015; 11(2):146-55.
PMID: 26679413
PMC: 4745133.
DOI: 10.1097/COH.0000000000000231.
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.
Adjei G, Goka B, Enweronu-Laryea C, Rodrigues O, Renner L, Sulley A
Malar J. 2014; 13:369.
PMID: 25236838
PMC: 4176868.
DOI: 10.1186/1475-2875-13-369.
Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART.
Rainwater-Lovett K, Nkamba H, Mubiana-Mbewe M, Moore C, Margolick J, Moss W
J Acquir Immune Defic Syndr. 2014; 67(5):455-62.
PMID: 25226208
PMC: 4229446.
DOI: 10.1097/QAI.0000000000000342.
The impact of differential antiviral immunity in children and adults.
Prendergast A, Klenerman P, Goulder P
Nat Rev Immunol. 2012; 12(9):636-48.
PMID: 22918466
DOI: 10.1038/nri3277.
Reference values of lymphocyte subsets in healthy, HIV-negative children in Cameroon.
Sagnia B, Ndongo F, Ndiang Moyo Tetang S, Torimiro J, Cairo C, Domkam I
Clin Vaccine Immunol. 2011; 18(5):790-5.
PMID: 21411603
PMC: 3122514.
DOI: 10.1128/CVI.00483-10.
Immunologic basis for revaccination of HIV-infected children receiving HAART.
Rainwater-Lovett K, Moss W
Future Virol. 2011; 6(1):59-71.
PMID: 21339832
PMC: 3039418.
DOI: 10.2217/fvl.10.75.
Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.
Charlebois E, Ruel T, Gasasira A, Achan J, Kateera F, Akello C
J Acquir Immune Defic Syndr. 2010; 55(3):330-5.
PMID: 20592617
PMC: 3025136.
DOI: 10.1097/QAI.0b013e3181e583da.